Literature DB >> 175944

Experimental evidence for the oncogenic potential of herpes simplex virus.

F Rapp, C Reed.   

Abstract

The data presented in this review reveal the transforming potential and oncogenic capability of herpes simplex viruses in cultured cells and in experimental animals, respectively. Unfortunately, the role of these agents in human cancer, especially cervical, cannot be unequivocally established through the indirect approaches used, but circumstantial evidence that these viruses represent potential oncogens in the human population is mounting.

Entities:  

Mesh：

Substances：

Year:  1976        PMID： 175944

Source DB:  PubMed          Journal:  Cancer Res        ISSN： 0008-5472            Impact factor:   12.701


  10 in total

1.  Cytosine-arabinoside does not inhibit incorporation of 3H-thymidine in herpes simplex virus transformed cells.

Authors:  J Roubal
Journal:  Arch Virol       Date:  1977       Impact factor: 2.574

2.  The role of immunology in the diagnosis, prognosis and treatment planning of oral cancer.

Authors:  E J Shillitoe
Journal:  Proc R Soc Med       Date:  1976-10

3.  Tumorigenic transformation induced by a specific fragment of DNA from herpes simplex virus type 2.

Authors:  R J Jariwalla; L Aurelian; P O Ts'o
Journal:  Proc Natl Acad Sci U S A       Date:  1980-04       Impact factor: 11.205

Review 4.  Persistence in herpes simplex virus infections.

Authors:  M Longson
Journal:  Postgrad Med J       Date:  1978-09       Impact factor: 2.401

5.  Escherichia coli-derived envelope protein gD but not gC antigens of herpes simplex virus protect mice against a lethal challenge with HSV-1 and HSV-2.

Authors:  M Bröker; K J Abel; R Köhler; J Hilfenhaus; E Amann
Journal:  Med Microbiol Immunol       Date:  1990       Impact factor: 3.402

6.  The association of viruses with urveal melanoma.

Authors:  D M Albert
Journal:  Trans Am Ophthalmol Soc       Date:  1979

7.  Protection from oral herpes simplex virus infection by a nucleic acid-free virus vaccine.

Authors:  E N Kitces; P S Morahan; J G Tew; B K Murray
Journal:  Infect Immun       Date:  1977-06       Impact factor: 3.441

8.  Animal studies on the efficacy of vaccination against recurrent herpes.

Authors:  M Scriba
Journal:  Med Microbiol Immunol       Date:  1982       Impact factor: 3.402

9.  Effect of pyran on latency after herpes simplex virus infections.

Authors:  P S Morahan; P F Cline; M C Breinig; B K Murray
Journal:  Antimicrob Agents Chemother       Date:  1979-04       Impact factor: 5.191

10.  Protectivity of herpes simplex virus antigens: studies in mice on the adjuvant effect of PICLC and on the dependence of protection on T cell competence.

Authors:  J Hilfenhaus; H Christ; R Köhler; H Moser; H Kirchner; H B Levy
Journal:  Med Microbiol Immunol       Date:  1981       Impact factor: 3.402
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.